Nausea Relief Chews Market Size & Share Global Analysis Report, 2023-2032
Nausea Relief Chews Market Size & Share Global Analysis Report, 2023-2032

Nausea Relief Chews Market Share, Size, Trends, Industry Analysis Report, By Indication (Poultry, Cattle, Swine, Horse, and Others); By Distribution Channel; By Distribution Channel; By Region; Segment Forecast, 2023 – 2032

  • Published Date:Dec-2023
  • Pages: 118
  • Format: PDF
  • Report ID: PM4090
  • Base Year: 2022
  • Historical Data: 2019-2021

Report Outlook

The global nausea relief chews market was valued at USD 416.73 million in 2022 and is expected to grow at a CAGR of 7.4% during the forecast period.

Nausea is a very common symptom associated with a wide range of medical conditions, such as motion sickness, pregnancy, post-operative nausea, and chemotherapy-induced nausea. Thus, the rapidly increasing prevalence of such conditions across the globe is driving the growth of the global market. Besides this, the growing popularity and proliferation of nausea relief chews, as they offer a highly convenient and easy-to-administer dosage form mainly for individuals having difficulties with swallowing pills and capsules, is likely to foster the growth and demand of the market significantly over the coming years.

Nausea Relief Chews Market Size

To Understand More About this Research: Request a Free Sample Report

  • For instance, as per a recent report published by the European Commission, around 4.09 million babies will be born in the European Union in 2021. Also, the total fertility rate in the European Union was estimated at 1.53 live births per woman, an increase from 2020, which was 1.50 live births per woman.

Many leading product manufacturers and suppliers around the world are incorporating natural and herbal ingredients that are highly known for their anti-nausea properties, such as ginger, peppermint, and lemon balm, among others, that lead to higher demand for products from consumers seeking natural remedies and gaining significant traction among health-conscious consumers.

Moreover, growing research & development efforts leading to the creation of new, faster-acting, and more effective formulations for nausea relief chews that include novel combinations of active ingredients and the development of sustained-release or extended-release chews that gradually release active ingredients over an extended period are anticipated to generate huge growth potential for the market.

Nausea Relief Chews Market Size

For Specific Research Requirements: Request for Customized Report

However, stringent regulatory compliance must be complied with by companies for the manufacturing and distribution of nausea relief chews and their use of a limited set of indications such as motion sickness, morning sickness, and chemotherapy-induced nausea, which are the key factors restricting the global market growth.  

Industry Dynamics

Growth Drivers

  • Increasing people's awareness about the potential benefits of nausea relief chews is fostering market growth.

The rising awareness and education across the globe about the availability and potential benefits of nausea relief chews through various awareness campaigns, advertisements, healthcare professionals, and online resources are key factors propelling the demand and growth of the global nausea relief chews market. Besides this, the availability of various types of nausea relief chews without a prescription and the emergence of various e-commerce platforms offering healthcare products, including nausea chews, that make them easily accessible to a wider range of consumers is further escalating the product demand at a rapid pace.  

  • For instance, according to a recent report, global e-commerce sales in the health & beauty sector are projected to reach a value of approx. USD 449.6 billion by 2027, with a healthy CAGR rate during the period.

Report Segmentation

The market is primarily segmented based on indication, distribution channel, and region.

By Indication

By Distribution Channel

By Region

  • Gastroesophageal Reflux Disease
  • Motion Sickness and Seasickness
  • Online Sales
  • Supermarkets & Hypermarkets
  • Hospital Pharmacies
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Indication Analysis

  • Motion sickness and seasickness segment accounted for the largest market share in 2022.

The motion sickness and seasickness segment accounted for the largest market share on account of a significant number of individuals experiencing motion sickness worldwide and the substantial growth in the number of people traveling by air, which led to a higher prevalence of motion sickness, especially during long-haul flights. Apart from this, the increasing availability of over-the-counter nausea relief chews at pharmacies, airports, and travel centers makes them easily accessible to travelers and contributes to their usage.

  • For instance, according to the International Air Transport Association, the global air traffic in the month of July 2023 rose by over 26.2% as compared to July 2022, and Asia Pacific airlines saw a robust growth of 105.8% in July 2023 from July 2022.  

The gastroesophageal reflux disease segment is expected to exhibit the highest growth during the projected period, mainly due to a significant increase in the prevalence of GRED globally and an increased preference for rapid relief to alleviate discomfort among individuals with GRED-related nausea. Additionally, these chews are gradually becoming an effective alternative or complementary option to prescriptions for managing GRED nausea more effectively.

By Distribution Channel Analysis

  • The online sales segment is expected to witness the highest growth over the forecast period.

The online sales segment is expected to witness the highest growth rate throughout the study period, owing to increasing online shopping trends and a drastic shift in consumer preferences towards online shopping platforms for healthcare products due to their numerous beneficial features, including convenience and accessibility, wider product selection from different brands, complete product information, and price comparison and better discounts, among many others.

  • For instance, according to a report by Forbes, around 20.8% of total retail purchases in 2023 are expected to take place online, and the number is estimated to reach 24% of retail purchases by 2026.

The hospital pharmacies segment led the market with substantial revenue share in 2022, which is mainly driven by a larger patient population in hospitals due to the presence of healthcare professionals, including physicians, specialists, and nurses, who play a vital role in prescribing medications, including nausea relief chews.

Regional Insights

  • North America region dominated the global market in 2022

The North America region dominated the global market. The regional market growth is highly attributable to its significant use in cancer treatment, especially for patients undergoing chemotherapy and radiation therapy, as these chews are specially designed to alleviate nausea and vomiting, which can be the side effects of these treatments. Thereby, with the rising incidences of cancer across the region, the need and demand for effective nausea relief chews is growing rapidly.

  • For instance, according to the American Cancer Society, the estimated number of new cancer cases and deaths due to cancer is around 1.9 million and 6,09,360, respectively, in the United States.  

The Asia Pacific region is anticipated to emerge as the growing region with a healthy CAGR over the forecast period, which is mainly attributed to a continuous surge in the aging population in countries like India and China, who are more likely to experience nausea-related health issues and presence of favorable regulations and policies supporting the growth of OTC pharmaceuticals including nausea relief products.    

  • For instance, according to the National Commission of Population, the elderly population in India was close to 9% in 2011, is growing at a significant pace, and could reach 18% of the country’s total population by 2036.  

In addition, the rising proliferation of busy urban lifestyles, irregular eating habits, and high-stress levels, particularly in cities, is significantly contributing to gastrointestinal issues and nausea. These growing issues are likely to positively foster the demand for nausea relief chews as they provide a quick and convenient solution for individuals with hectic lifestyles.

Key Market Players & Competitive Insights

The nausea relief chews market is highly fragmented, with the robust presence of several large market players. The top market players operating in the market are significantly focusing on several business development and expansion strategies, including partnerships, collaborations, acquisitions & mergers, and new product launches to cater to a wider customer base and expand their geographical presence into emerging markets.

Some of the major players operating in the global market include:

  • Cipla
  • Emetrol Chewables
  • Ginger People
  • Megafood
  • Mighty Petz
  • Pepto Bismol
  • Pink Stork
  • Prestige Consumer Healthcare Inc.
  • Sanofi
  • Sea Calm
  • Sea-Band
  • Three Lollies
  • Upspring
  • Webber Naturals

Recent Developments

  • In October 2022, Axsome Therapeutics announced the launch of AUVELITY in the United States, mainly for the treatment of major depressive disorder in adults.
  • In September 2021, RELIEF THERAPEUTICS Holding introduced its PKU GOLIKE KRUNCH, which is a chewable tablet designed for the management of phenylketonuria in Italy and Germany. This rare and recessive metabolic genetic disorder affects approximately 3,50,000 people worldwide.

Nausea Relief Chews Market Report Scope

Report Attributes


Market size value in 2023

USD 444.27 million

Revenue forecast in 2032

USD 841.40 million


7.4% from 2023 – 2032

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Indication, By Distribution Channel, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.